Article

NovaPure® Stoppers - The Right Choice For Oncology Drugs

Source: West Pharmaceutical Services, Inc.

By L. Fang, M. Gehrmann, R. Singh, C. Zhao, P. McAndrew

image1

Vial containment systems with NovaPure® elastomer stoppers offer substantial performance benefits. There are several reasons: enhanced dimension control, reduced particle levels, inspection of every stopper, and use of FluroTec® film. Based on fluoropolymer chemistry, FluroTec film reduce both migration of leachables from stoppers into drug products, and interaction of drug products with stoppers. And as compared to stoppers without films, there is no change in long-term container closure integrity (CCI) performance. This article presents research that demonstrates the performance of FluroTec film, and thus illustrates why NovaPure stoppers should be the choice for sensitive drug products such as those for oncology.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development

Please tell us more about you so that we can customize our newsletters to your specific interests:

West Pharmaceutical Services, Inc.